Analysts See $0.06 EPS for HealthStream, Inc. (HSTM)

April 20, 2018 - By Peter Erickson

HealthStream, Inc. (NASDAQ:HSTM) LogoInvestors sentiment decreased to 1.22 in Q4 2017. Its down 0.39, from 1.61 in 2017Q3. It worsened, as 10 investors sold HealthStream, Inc. shares while 41 reduced holdings. 20 funds opened positions while 42 raised stakes. 22.64 million shares or 3.29% less from 23.41 million shares in 2017Q3 were reported.
Old National Bancorporation In has 0.02% invested in HealthStream, Inc. (NASDAQ:HSTM). Comerica Commercial Bank holds 0.01% or 53,176 shares. Trexquant Investment Limited Partnership stated it has 0.04% in HealthStream, Inc. (NASDAQ:HSTM). 981 were accumulated by Greenleaf Tru. Moreover, Laurion Cap Mngmt L P has 0% invested in HealthStream, Inc. (NASDAQ:HSTM) for 10,219 shares. Great West Life Assurance Can reported 0% in HealthStream, Inc. (NASDAQ:HSTM). Bnp Paribas Arbitrage Sa stated it has 10,689 shares or 0% of all its holdings. California-based Assetmark Inc has invested 0% in HealthStream, Inc. (NASDAQ:HSTM). Tower Capital (Trc), a New York-based fund reported 307 shares. Bessemer Group invested 0% of its portfolio in HealthStream, Inc. (NASDAQ:HSTM). Teachers Retirement Sys Of The State Of Kentucky has invested 0% of its portfolio in HealthStream, Inc. (NASDAQ:HSTM). 52,526 are held by Panagora Asset Inc. Emerald Mutual Fund Advisers Trust invested 0.2% of its portfolio in HealthStream, Inc. (NASDAQ:HSTM). Pembroke Mngmt Ltd holds 2.02% of its portfolio in HealthStream, Inc. (NASDAQ:HSTM) for 850,128 shares. Citigroup Inc reported 11,473 shares stake.

Since February 23, 2018, it had 0 buys, and 6 sales for $2.27 million activity. REBROVICK LINDA had sold 21,000 shares worth $508,200. HAYDEN GERARD M JR also sold $607,959 worth of HealthStream, Inc. (NASDAQ:HSTM) shares. Another trade for 10,452 shares valued at $251,488 was sold by HARRIS C MARTIN. Taylor Tate Deborah also sold $291,799 worth of HealthStream, Inc. (NASDAQ:HSTM) shares.

Analysts expect HealthStream, Inc. (NASDAQ:HSTM) to report $0.06 EPS on April, 30 after the close.They anticipate $0.02 EPS change or 50.00 % from last quarter’s $0.04 EPS. HSTM’s profit would be $1.94M giving it 102.54 P/E if the $0.06 EPS is correct. After having $0.04 EPS previously, HealthStream, Inc.’s analysts see 50.00 % EPS growth. The stock decreased 1.28% or $0.32 during the last trading session, reaching $24.61. About 47,919 shares traded. HealthStream, Inc. (NASDAQ:HSTM) has risen 8.54% since April 20, 2017 and is uptrending. It has underperformed by 3.01% the S&P500.

HealthStream, Inc. (NASDAQ:HSTM) Ratings Coverage

Among 4 analysts covering HealthStream (NASDAQ:HSTM), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. HealthStream had 6 analyst reports since October 23, 2017 according to SRatingsIntel. The rating was maintained by Robert W. Baird on Wednesday, October 25 with “Outperform”. Cantor Fitzgerald maintained HealthStream, Inc. (NASDAQ:HSTM) on Tuesday, February 20 with “Hold” rating. As per Monday, October 23, the company rating was maintained by Needham. Cantor Fitzgerald maintained HealthStream, Inc. (NASDAQ:HSTM) on Monday, October 23 with “Hold” rating. The firm has “Hold” rating given on Wednesday, October 25 by Needham.

HealthStream, Inc. provides workforce, patient experience, and well-known provider solutions to the healthcare organizations in the United States. The company has market cap of $794.89 million. The firm operates in three divisions: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions, and HealthStream Provider Solutions. It has a 79.39 P/E ratio. It offers workforce development solutions comprising software-as-a-service and subscription products to meet talent management, training, certification, competency assessment, performance appraisal, and development needs, as well as training, implementation, and account management services.

HealthStream, Inc. (NASDAQ:HSTM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.